This project aims to identify brain-based EEG markers of self-efficacy and self-regulation, which are the two critical treatment targets for people with chronic pain and comorbid heavy alcohol use. Such objective markers will assist in accurate diagnosis and assessment of treatment responses, which may enable a precision medicine approach for chronic pain and substance use disorders.
